SUMMARY Cimetidine markedly inhibits gastric acid secretion, but from the therapeutic point of view it is important to know whether concurrent treatment with an anticholinergic increases its effect. This possibility has been investigated by measuring the 24 h intragastric acidity and nocturnal output of acid in four duodenal ulcer patients, each receiving on separate occasions cimetidine 1 g/day and placebo, atropine 2-4 mg/day and placebo, cimetidine and atropine, or two placebos.Cimetidine alone decreased mean hourly hydrogen ion activity by 63 % of control values, decreased mean hourly hydrogen ion concentration (total acid) by 41 %, inhibited nocturnal acid secretion by 830% and resulted in half the nocturnal samples being anacidic. Atropine alone had no effect when compared with control and combined treatment with both drugs was not superior to cimetidine alone. Atropine did not affect the absorption or urinary excretion of cimetidine. Fasting serum gastrin concentrations were not changed by any of the treatments.At the doses studied, the combination of cimetidine with an anticholinergic appears to offer no advantages over treatment with the H2-antagonist alone. Cimetidine is the only potent anti-secretory drug that does not cause acute side-effects and this important advantage would be lost if it were given with a maximal dose of an anticholinergic.There is experimental and clinical evidence to suggest that the actions of a histamine H2-receptor antagonist and an anticholinergic might be additive or even synergistic (Thjodleifsson and Wormsley, 1974;Richardson et al., 1975;Thompson et al., 1975;Richardson and Walsh, 1976).The object of the present study was to determine whether combined treatment with cimetidine and an anticholinergic is likely to be more effective than either drug alone.
MethodsFour male patients, weighing 62-3, 85-5, 85-9 and 85 9 kg and aged 33, 19, 21 and 24 years respectively, were studied for 24 h periods on the same days of 'Reprint requests: